Combined Metabolic Activators Therapy Reduces Liver Fat by 10% In Nonalcoholic Fatty Liver Disease Patients

A recent phase 2 clinical trial published on Cell Press Sneak Peek, a preprint publication website for papers under review by Cell Press Journals, found that a novel combined metabolic cofactor sup...

NAD+ Liver Depletion is Linked to Alcohol-Related Liver Disease in Humans

A new study recently published in Hepatology Communications  and conducted by investigators from The University of Birmingham, its affiliated hospital, and the University of Iowa, found that NAD+ l...

NR Shows Potential to Reduce Fatty Liver in People

A clinical study conducted at the University of Copenhagen, Aarhus University Hospital and the University of Iowa has provided the first human evidence of the potential for nicotinamide riboside (N...